surmount-1 trial tirzepatide weight loss nondiabetic SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized, SURMOUNT-1: Tirzepatide Drastically Reduces Weight

It is not a drug, not a supplement, not a cosmetic and not a medical device

Individual Safety Profile: Suitability depends on diagnosis, medical history, current medications, and clinician evaluation

The battery provided an age-adjusted composite scores of overall cognition 56 for each test session based on seven cognitive function tests: a flanker inhibitory control and attention test 57 , a picture sequence memory test 58 , a list sorting working memory test 59 , a picture vocabulary test 60 , an oral reading recognition test 60 , dimensional change card sort test 57 and a pattern comparison processing speed test 61

And the benefits aren't just physical they're mental, too

Can I combine Tirzepatide with other weight loss strategies